Next |
home / stock / chrs / chrs message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts gaining last up | DewDiligence | investorshub | 05/09/2023 8:42:13 PM |
$CHRS good read | DewDiligence | investorshub | 05/08/2023 4:47:45 PM |
short data if anyone is interested | dinogreeves | investorshub | 05/08/2023 11:07:14 AM |
should we be shorting? | DewDiligence | investorshub | 05/08/2023 6:16:37 AM |
$CHRS must see | dinogreeves | investorshub | 05/08/2023 5:57:13 AM |
Price now | dinogreeves | investorshub | 05/06/2023 5:15:58 AM |
$CHRS Price trading | tika1 | investorshub | 05/04/2023 1:30:09 AM |
Found an interesting article | stock1ace1 | investorshub | 05/03/2023 7:37:15 AM |
$CHRS are we finally gonna see some action | dinogreeves | investorshub | 05/03/2023 4:43:55 AM |
$CHRS bears and bulls | SmokeSignals | investorshub | 04/29/2023 9:07:55 PM |
MomentumIts gaining last up | DewDiligence | investorshub | 04/29/2023 3:27:46 AM |
$CHRS Time for a bounce? | dinogreeves | investorshub | 04/25/2023 9:04:02 PM |
The trading up | SmokeSignals | investorshub | 04/25/2023 12:19:49 PM |
Price now | SmokeSignals | investorshub | 04/21/2023 6:23:54 PM |
$CHRS Anyone hear anything lately? Want to see this one go | crudeoil24 | investorshub | 04/20/2023 6:43:36 PM |
$CHRS news all the way baby | Dr Speculator Ninja | investorshub | 04/19/2023 10:36:36 AM |
The trading | DewDiligence | investorshub | 04/17/2023 9:12:56 PM |
Hey...I went and bought a handful of calls | SmokeSignals | investorshub | 01/05/2023 2:30:04 PM |
whytestocks: $CHRS News Article - Coherus BioSciences Management to Present at the 41st Annual J.P. | whytestocks | investorshangout | 01/04/2023 3:15:49 PM |
hey..have a great holiday! let me know whats | SmokeSignals | investorshub | 12/23/2022 7:23:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Coherus BioSciences Inc. Company Name:
CHRS Stock Symbol:
NASDAQ Market:
Coherus BioSciences Inc. Website:
REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ((Coherus, NASDAQ:CHRS) today announced the first presentatio...
REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8 antibody, at the upcoming ASCO Annual Meeting, which will be held from May 31 ...
– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activati...